A study on 66 GBC patients reported that 54% of patients were IHC positive for PD-L1 expression; in particular, 18% and 36% of positivity were found for tumor cells and peritumoral immune stroma, respectively [65]. This evidence concerns the gene CD274 and neoplasm.